mounjaro vs semaglutide for weight loss Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough the treatment of obesity Mounjaro vs Ozempic for Weight
Description
The trial found that semaglutide 1.0 mg demonstrated a statistically significant and superior 24% risk reduction in kidney disease progression as well as cardiovascular and kidney death compared to placebo
Tiani says
Serious side effects are rare but include severe abdominal pain, pancreatitis symptoms, or signs of hyperthyroidism (rapid heartbeat, tremors)
Restarting tirzepatide after a surgical interruption may be associated with a recurrence of gastrointestinal side effects, even in patients who previously tolerated the medication well
